1. Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7):810-819 February 18, 2016 ©2016 by American Society of Hematology

2. The sickle red blood cell (SS RBC) as source of multiple pathophysiologic pathways. Marilyn J. Telen Blood 2016;127:810-819 ©2016 by American Society of Hematology

3. Adhesive interactions involving SS RBCs. (A) Multiple interactions between SS RBCs and endothelial cells, extracellular matrix, and plasma proteins. Marilyn J. Telen Blood 2016;127:810-819 ©2016 by American Society of Hematology